News | Nipro

R&D at Nipro

3% of Japan’s GDP goes to Research & Development. The strategy for Japan’s R&D approach has changed over the years. What does Nipro place emphasis on in its strategy?

Synergies within Nipro

Introducing the synergy between medical devices, pharmaceutical drugs and pharmaceutical packaging.

Nipro assumes its role and establishes a stable supply

To establish a stable supply requires spending a significant amount for the production processes.

Pharmaceutical Packaging

Nipro breaks ground in Aumale (France) for new facility

As announced in 2020, Nipro is investing over 60 million USD in its facilities in France and the US. With this investment, Nipro strengthens its position as a leading global supplier of glass primary packaging for the pharmaceutical industry.

Pharmaceutical Packaging

A commitment to quality, safety, and the environment

A commitment to quality, safety and environment.

Pharmaceutical Packaging

Nipro's syringes expansion continues!

Nipro PharmaPackaging is expanding the manufacturing capacity of pre-fillable glass syringes.

Pharmaceutical Packaging

CURACASE™ In The Spotlight

Pharmaceutical Packaging

Nipro successfully completed the acquisition of Piramida, Croatia

Nipro PharmaPackaging is strengthening its position as a leading global supplier of glass primary packaging for the pharmaceutical industry.

Pharmaceutical Packaging

D2F syringes fully compatible with Needle-Trap!

We are delighted to expand our portfolio, announcing that Nipro D2F™ pre-fillable glass syringes have been tested and are fully compatible with Schreiner MediPharm’s Needle-Trap.1